Skip to main content
. 2021 Nov 29;13(12):2034. doi: 10.3390/pharmaceutics13122034

Figure 3.

Figure 3

An illustration of the possible antiviral mechanisms of silver nanoparticles (AgNPs): (1) interaction of AgNPs with the viral surface; (2) interface with the cell membrane while blocking the viral attachment; (3) inhibition of cellular pathways of the virus; (4) interaction with viral genome; (5) interaction to inhibit viral genome replication; (6) inhibition of cellular factors (i.e., protein synthesis) necessary for viral replication.